Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice

T Uchida, T Nakamura, N Hashimoto, T Matsuda… - Nature medicine, 2005 - nature.com
T Uchida, T Nakamura, N Hashimoto, T Matsuda, K Kotani, H Sakaue, Y Kido, Y Hayashi…
Nature medicine, 2005nature.com
The protein p27Kip1 regulates cell cycle progression in mammals by inhibiting the activity of
cyclin-dependent kinases (CDKs). Here we show that p27Kip1 progressively accumulates in
the nucleus of pancreatic beta cells in mice that lack either insulin receptor substrate 2
(Irs2−/−) or the long form of the leptin receptor (Lepr−/− or db/db). Deletion of the gene
encoding p27Kip1 (Cdkn1b) ameliorated hyperglycemia in these animal models of type 2
diabetes mellitus by increasing islet mass and maintaining compensatory hyperinsulinemia …
Abstract
The protein p27Kip1 regulates cell cycle progression in mammals by inhibiting the activity of cyclin-dependent kinases (CDKs). Here we show that p27Kip1 progressively accumulates in the nucleus of pancreatic beta cells in mice that lack either insulin receptor substrate 2 (Irs2−/−) or the long form of the leptin receptor (Lepr−/− or db/db). Deletion of the gene encoding p27Kip1 (Cdkn1b) ameliorated hyperglycemia in these animal models of type 2 diabetes mellitus by increasing islet mass and maintaining compensatory hyperinsulinemia, effects that were attributable predominantly to stimulation of pancreatic beta-cell proliferation. Thus, p27Kip1 contributes to beta-cell failure during the development of type 2 diabetes in Irs2−/− and Lepr−/− mice and represents a potential new target for the treatment of this condition.
nature.com